An update on treatment options for pancreatic adenocarcinoma
Aurélien Lambert(Institut de Cancérologie de Lorraine), Thierry Conroy(Inserm), Lilian Schwarz(Université de Rouen Normandie), Michel Ducreux(Université Paris-Saclay), Aline Henry(Institut de Cancérologie de Lorraine), Ivan Borbath, Jean–Luc Van Laethem, David Malka(Inserm)
Cited by 211
Related Papers
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.8k
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
|Journal of Clinical Oncology|2011|2.1k
Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203
|Journal of Clinical Oncology|2006|1.7k
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.3k